← Open Payments lookup

LEA GRIPPIN: Open Payments

NPI 1891204475 · NORTHAMPTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,380 in 109 payments from 20 companies in 2025. Trend: 2023 $125 · 2024 $1,503 · 2025 $2,380

Food & beverage: $2,280Education: $100
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP20$481
Regeneron Healthcare Solutions, Inc.16$287
CSL Behring8$228
Amgen Inc.12$204
Genentech USA, Inc.10$201
GENZYME CORPORATION8$159
GlaxoSmithKline, LLC.6$139
Lilly USA, LLC5$116
SANOFI-AVENTIS U.S. LLC1$100
Takeda Pharmaceuticals U.S.A., Inc.4$96

Products named: DUPIXENT, TEZSPIRE, Xolair, FASENRA, AIRSUPRA, EBGLYSS, TRELEGY ELLIPTA, TAKHZYRO.

Industry payments across MA — which companies pay providers there.